top of page

UC/CCHMC Representation at the CATHIA Research Symposium

  • Writer: UC CCTST
    UC CCTST
  • Feb 9, 2024
  • 1 min read

Updated: Apr 24, 2024

CCTST KL2 Associate Director, Moises Huaman, MD, along with colleagues at UC/CCHMC, partnered with Impacta PERU and Peru Clinical Trials Unit (CTU) to host the second CATHIA (Coronary Atherosclerosis and TB HIV Immune Activation) Research Symposium in Lima, Peru. The UC/CCHMC delegation included Claire Chougnet, PhD, Elaine Urbina, MD, Carl Fichtenbaum, MD, Rocio Egoavil, and Pablo Alarcon.



The research symposium focused on the interplay between infection and non-communicable diseases. Impacta PERU and Peru CTU are part of Dr. Huaman’s R01, which is expanding clinical and translational science collaborations with colleagues in Peru and globally.


Academic sponsors for the symposium included the UC Center for Cardiovascular Research.

Become a member and get access to research resources and services offered by the CCTST. Click here to apply.

CONTACT US:

CCTST: cctst@uc.edu 

REDCap: help-redcap@bmi.cchmc.org

240 Albert Sabin Way, Location S, Suite 2.200

Cincinnati, Ohio 45229

The Clinical and Translational Science Awards (CTSA) is a registered trademark of DHHS NIH Acknowledgment:

 

Publications resulting from use of CCTST resources must credit the appropriate CCTST grant by including an NIH Funding acknowledgment: The CCTST at the University of Cincinnati is funded by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grant UL1TR001425. The CTSA program is led by the NIH’s National Center for Advancing Translational Sciences (NCATS). The content of this website is solely the responsibility of the CCTST and does not necessarily represent the official views of the NIH.

bottom of page